Report Detail

Pharma & Healthcare Global Ranitidine (Zantac) Market Insights and Forecast to 2027

  • RnM4288011
  • |
  • 22 June, 2021
  • |
  • Global
  • |
  • 145 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Ranitidine (Zantac) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ranitidine (Zantac) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Ranitidine Capsule
Ranitidine Oral Tablet
Ranitidine Injectable Solution
Ranitidine Oral Syrup

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Company
Sanofi-Aventis
GlaxoSmithKline
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia


1 Study Coverage

  • 1.1 Ranitidine (Zantac) Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Ranitidine (Zantac) Market Size Growth Rate by Type
    • 1.4.2 Ranitidine Capsule
    • 1.4.3 Ranitidine Oral Tablet
    • 1.2.4 Ranitidine Injectable Solution
    • 1.2.5 Ranitidine Oral Syrup
  • 1.3 Market by Application
    • 1.3.1 Global Ranitidine (Zantac) Market Size Growth Rate by Application
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Online Pharmacy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Ranitidine (Zantac) Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Ranitidine (Zantac) Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Ranitidine (Zantac) Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Ranitidine (Zantac) Regions by Sales
    • 2.4.1 Global Top Ranitidine (Zantac) Regions by Sales (2016-2021)
    • 2.4.2 Global Top Ranitidine (Zantac) Regions by Sales (2022-2027)
  • 2.5 Global Top Ranitidine (Zantac) Regions by Revenue
    • 2.5.1 Global Top Ranitidine (Zantac) Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Ranitidine (Zantac) Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Ranitidine (Zantac) Sales by Manufacturers
    • 3.1.1 Global Top Ranitidine (Zantac) Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Ranitidine (Zantac) Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Ranitidine (Zantac) Sales in 2020
  • 3.2 Global Ranitidine (Zantac) Revenue by Manufacturers
    • 3.2.1 Global Top Ranitidine (Zantac) Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Ranitidine (Zantac) Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Ranitidine (Zantac) Revenue in 2020
  • 3.3 Global Ranitidine (Zantac) Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Ranitidine (Zantac) Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Ranitidine (Zantac) Sales by Type
    • 4.1.1 Global Ranitidine (Zantac) Historical Sales by Type (2016-2021)
    • 4.1.2 Global Ranitidine (Zantac) Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Ranitidine (Zantac) Sales Market Share by Type (2016-2027)
  • 4.2 Global Ranitidine (Zantac) Revenue by Type
    • 4.2.1 Global Ranitidine (Zantac) Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Ranitidine (Zantac) Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Ranitidine (Zantac) Revenue Market Share by Type (2016-2027)
  • 4.3 Global Ranitidine (Zantac) Price by Type
    • 4.3.1 Global Ranitidine (Zantac) Price by Type (2016-2021)
    • 4.3.2 Global Ranitidine (Zantac) Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Ranitidine (Zantac) Sales by Application
    • 5.1.1 Global Ranitidine (Zantac) Historical Sales by Application (2016-2021)
    • 5.1.2 Global Ranitidine (Zantac) Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Ranitidine (Zantac) Sales Market Share by Application (2016-2027)
  • 5.2 Global Ranitidine (Zantac) Revenue by Application
    • 5.2.1 Global Ranitidine (Zantac) Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Ranitidine (Zantac) Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Ranitidine (Zantac) Revenue Market Share by Application (2016-2027)
  • 5.3 Global Ranitidine (Zantac) Price by Application
    • 5.3.1 Global Ranitidine (Zantac) Price by Application (2016-2021)
    • 5.3.2 Global Ranitidine (Zantac) Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Ranitidine (Zantac) Market Size by Type
    • 6.1.1 North America Ranitidine (Zantac) Sales by Type (2016-2027)
    • 6.1.2 North America Ranitidine (Zantac) Revenue by Type (2016-2027)
  • 6.2 North America Ranitidine (Zantac) Market Size by Application
    • 6.2.1 North America Ranitidine (Zantac) Sales by Application (2016-2027)
    • 6.2.2 North America Ranitidine (Zantac) Revenue by Application (2016-2027)
  • 6.3 North America Ranitidine (Zantac) Market Size by Country
    • 6.3.1 North America Ranitidine (Zantac) Sales by Country (2016-2027)
    • 6.3.2 North America Ranitidine (Zantac) Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Ranitidine (Zantac) Market Size by Type
    • 7.1.1 Europe Ranitidine (Zantac) Sales by Type (2017-2027)
    • 7.1.2 Europe Ranitidine (Zantac) Revenue by Type (2017-2027)
  • 7.2 Europe Ranitidine (Zantac) Market Size by Application
    • 7.2.1 Europe Ranitidine (Zantac) Sales by Application (2017-2027)
    • 7.2.2 Europe Ranitidine (Zantac) Revenue by Application (2017-2027)
  • 7.3 Europe Ranitidine (Zantac) Market Size by Country
    • 7.3.1 Europe Ranitidine (Zantac) Sales by Country (2017-2027)
    • 7.3.2 Europe Ranitidine (Zantac) Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Ranitidine (Zantac) Market Size by Type
    • 8.1.1 Asia Pacific Ranitidine (Zantac) Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Ranitidine (Zantac) Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Ranitidine (Zantac) Market Size by Application
    • 8.2.1 Asia Pacific Ranitidine (Zantac) Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Ranitidine (Zantac) Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Ranitidine (Zantac) Market Size by Region
    • 8.3.1 Asia Pacific Ranitidine (Zantac) Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Ranitidine (Zantac) Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Ranitidine (Zantac) Market Size by Type
    • 9.1.1 Latin America Ranitidine (Zantac) Sales by Type (2019-2027)
    • 9.1.2 Latin America Ranitidine (Zantac) Revenue by Type (2019-2027)
  • 9.2 Latin America Ranitidine (Zantac) Market Size by Application
    • 9.2.1 Latin America Ranitidine (Zantac) Sales by Application (2019-2027)
    • 9.2.2 Latin America Ranitidine (Zantac) Revenue by Application (2019-2027)
  • 9.3 Latin America Ranitidine (Zantac) Market Size by Country
    • 9.3.1 Latin America Ranitidine (Zantac) Sales by Country (2019-2027)
    • 9.3.2 Latin America Ranitidine (Zantac) Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Ranitidine (Zantac) Market Size by Type
    • 6.1.1 Middle East and Africa Ranitidine (Zantac) Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Ranitidine (Zantac) Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Ranitidine (Zantac) Market Size by Application
    • 6.2.1 Middle East and Africa Ranitidine (Zantac) Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Ranitidine (Zantac) Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Ranitidine (Zantac) Market Size by Country
    • 6.3.1 Middle East and Africa Ranitidine (Zantac) Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Ranitidine (Zantac) Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 UAE

11 Company Profiles

  • 11.1 Sanofi-Aventis
    • 11.1.1 Sanofi-Aventis Corporation Information
    • 11.1.2 Sanofi-Aventis Overview
    • 11.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Sanofi-Aventis Ranitidine (Zantac) Product Description
    • 11.1.5 Sanofi-Aventis Related Developments
  • 11.2 GlaxoSmithKline
    • 11.2.1 GlaxoSmithKline Corporation Information
    • 11.2.2 GlaxoSmithKline Overview
    • 11.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 GlaxoSmithKline Ranitidine (Zantac) Product Description
    • 11.2.5 GlaxoSmithKline Related Developments
  • 11.3 Hi-Tech Pharmacal Co.
    • 11.3.1 Hi-Tech Pharmacal Co. Corporation Information
    • 11.3.2 Hi-Tech Pharmacal Co. Overview
    • 11.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Description
    • 11.3.5 Hi-Tech Pharmacal Co. Related Developments
  • 11.4 Sun Pharma
    • 11.4.1 Sun Pharma Corporation Information
    • 11.4.2 Sun Pharma Overview
    • 11.4.3 Sun Pharma Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Sun Pharma Ranitidine (Zantac) Product Description
    • 11.4.5 Sun Pharma Related Developments
  • 11.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
    • 11.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information
    • 11.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Overview
    • 11.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Description
    • 11.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Related Developments
  • 11.6 Dr. Reddy’s Laboratories Inc.
    • 11.6.1 Dr. Reddy’s Laboratories Inc. Corporation Information
    • 11.6.2 Dr. Reddy’s Laboratories Inc. Overview
    • 11.6.3 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product Description
    • 11.6.5 Dr. Reddy’s Laboratories Inc. Related Developments
  • 11.7 Sandoz Inc. (part of Novartis AG)
    • 11.7.1 Sandoz Inc. (part of Novartis AG) Corporation Information
    • 11.7.2 Sandoz Inc. (part of Novartis AG) Overview
    • 11.7.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Description
    • 11.7.5 Sandoz Inc. (part of Novartis AG) Related Developments
  • 11.8 Strides (and Strides Arcolab international)
    • 11.8.1 Strides (and Strides Arcolab international) Corporation Information
    • 11.8.2 Strides (and Strides Arcolab international) Overview
    • 11.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Description
    • 11.8.5 Strides (and Strides Arcolab international) Related Developments
  • 11.9 Geri-Care Pharmaceuticals
    • 11.9.1 Geri-Care Pharmaceuticals Corporation Information
    • 11.9.2 Geri-Care Pharmaceuticals Overview
    • 11.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Description
    • 11.9.5 Geri-Care Pharmaceuticals Related Developments
  • 11.10 PAI Holdings, LLC
    • 11.10.1 PAI Holdings, LLC Corporation Information
    • 11.10.2 PAI Holdings, LLC Overview
    • 11.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 PAI Holdings, LLC Ranitidine (Zantac) Product Description
    • 11.10.5 PAI Holdings, LLC Related Developments
  • 11.1 Sanofi-Aventis
    • 11.1.1 Sanofi-Aventis Corporation Information
    • 11.1.2 Sanofi-Aventis Overview
    • 11.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Sanofi-Aventis Ranitidine (Zantac) Product Description
    • 11.1.5 Sanofi-Aventis Related Developments
  • 11.12 Granules Pharmaceuticals Inc.
    • 11.12.1 Granules Pharmaceuticals Inc. Corporation Information
    • 11.12.2 Granules Pharmaceuticals Inc. Overview
    • 11.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Granules Pharmaceuticals Inc. Product Description
    • 11.12.5 Granules Pharmaceuticals Inc. Related Developments
  • 11.13 Glenmark Pharmaceuticals (and Glenmark Generics)
    • 11.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information
    • 11.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Overview
    • 11.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Product Description
    • 11.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Related Developments
  • 11.14 Apotex Inc. (and Apotex Corporation)
    • 11.14.1 Apotex Inc. (and Apotex Corporation) Corporation Information
    • 11.14.2 Apotex Inc. (and Apotex Corporation) Overview
    • 11.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.14.4 Apotex Inc. (and Apotex Corporation) Product Description
    • 11.14.5 Apotex Inc. (and Apotex Corporation) Related Developments
  • 11.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)
    • 11.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information
    • 11.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Overview
    • 11.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Product Description
    • 11.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Ranitidine (Zantac) Value Chain Analysis
  • 12.2 Ranitidine (Zantac) Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Ranitidine (Zantac) Production Mode & Process
  • 12.4 Ranitidine (Zantac) Sales and Marketing
    • 12.4.1 Ranitidine (Zantac) Sales Channels
    • 12.4.2 Ranitidine (Zantac) Distributors
  • 12.5 Ranitidine (Zantac) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Ranitidine (Zantac) Industry Trends
  • 13.2 Ranitidine (Zantac) Market Drivers
  • 13.3 Ranitidine (Zantac) Market Challenges
  • 13.4 Ranitidine (Zantac) Market Restraints

14 Key Findings in The Global Ranitidine (Zantac) Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Summary:
    Get latest Market Research Reports on Ranitidine (Zantac). Industry analysis & Market Report on Ranitidine (Zantac) is a syndicated market report, published as Global Ranitidine (Zantac) Market Insights and Forecast to 2027. It is complete Research Study and Industry Analysis of Ranitidine (Zantac) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,910.20
    5,865.30
    7,820.40
    4,571.70
    6,857.55
    9,143.40
    753,424.00
    1,130,136.00
    1,506,848.00
    408,954.00
    613,431.00
    817,908.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report